Singapore markets closed
Straits Times Index
3,095.59 -6.62 (-0.21%) Nikkei
25,935.62 -457.42 (-1.73%) Hang Seng
21,859.79 -137.10 (-0.62%) FTSE 100
7,168.65 -0.63 (-0.01%) BTC-USD
19,068.21 -134.99 (-0.70%) CMC Crypto 200
420.84 +0.70 (+0.17%)
MannKind Corporation (MNKD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.8100 |
| Open | 3.8100 |
| Bid | 3.8000 x 28000 |
| Ask | 4.0000 x 1200 |
| Day's range | 3.8000 - 4.0000 |
| 52-week range | 2.4900 - 5.4400 |
| Volume | |
| Avg. volume | 5,489,888 |
| Market cap | 1.005B |
| Beta (5Y monthly) | 1.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3750 |
| Earnings date | 09 Aug 2022 - 15 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.00 |
- Zacks
Allogene Therapeutics (ALLO) Moves 16.4% Higher: Will This Strength Last?
Allogene Therapeutics (ALLO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Zacks
United Therapeutics (UTHR) Gains on Tyvaso DPI Approval
The FDA approves United Therapeutics' (UTHR) drug-device combination therapy, Tyvaso DPI, for PAH patients. It is a dry-powder inhalation formulation of Treprostinil. Stock gains 8.8%.
- Motley Fool
MannKind Corporation (MNKD) Q1 2022 Earnings Call Transcript
As a reminder, this call is being recorded on May 5, 2022, and will be available for playback on the MannKind Corporation's website shortly after the conclusion of this call until May 19, 2022. Joining us today from MannKind are chief executive officer, Michael Castagna; and chief financial officer, Steven Binder.
© 2022 Yahoo. All rights reserved.
